BBC holdings
Virtus Biotech Clinical Trials ETF
Positions
132 stored of 132 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 101 | PROTHENA CORP PLC PROTHENA CORP PLC SHS | IE00B91XRN20 | Not reported | 0.659% | $306K | Equity (common) | Corporate | Ireland | USD |
| 102 | ARRIVENT BIOPHARMA INC ARRIVENT BIOPHARMA INC COM | US04272N1028 | 04272N102 | 0.654% | $303K | Equity (common) | Corporate | United States | USD |
| 103 | CELCUITY INC CELCUITY INC COM | US15102K1007 | 15102K100 | 0.654% | $303K | Equity (common) | Corporate | United States | USD |
| 104 | STOKE THERAPEUTICS INC STOKE THERAPEUTICS INC COM | US86150R1077 | 86150R107 | 0.648% | $301K | Equity (common) | Corporate | United States | USD |
| 105 | SEPTERNA INC SEPTERNA INC COM | US81734D1046 | 81734D104 | 0.642% | $298K | Equity (common) | Corporate | United States | USD |
| 106 | BICYCLE THERAPEUTICS PLC BICYCLE THERAPEUTICS PLC SPONSORED ADS | US0887861088 | 088786108 | 0.639% | $296K | Equity (common) | Corporate | United Kingdom | USD |
| 107 | RECURSION PHARMACEUTICALS INC RECURSION PHARMACEUTICALS INC CL A | US75629V1044 | 75629V104 | 0.638% | $296K | Equity (common) | Corporate | United States | USD |
| 108 | ANAPTYSBIO INC ANAPTYSBIO INC COM | US0327241065 | 032724106 | 0.638% | $296K | Equity (common) | Corporate | United States | USD |
| 109 | LEXEO THERAPEUTICS INC LEXEO THERAPEUTICS INC COM | US52886X1072 | 52886X107 | 0.633% | $294K | Equity (common) | Corporate | United States | USD |
| 110 | COMPASS THERAPEUTICS INC COMPASS THERAPEUTICS INC COM | US20454B1044 | 20454B104 | 0.630% | $292K | Equity (common) | Corporate | United States | USD |
| 111 | EYEPOINT INC EYEPOINT INC COM NEW | US30233G2093 | 30233G209 | 0.630% | $292K | Equity (common) | Corporate | United States | USD |
| 112 | COMPASS PATHWAYS PLC COMPASS PATHWAYS PLC SPONSORED ADS | US20451W1018 | 20451W101 | 0.630% | $292K | Equity (common) | Corporate | United Kingdom | USD |
| 113 | PROKIDNEY CORP PROKIDNEY CORP SHS CL A | US74291D1046 | 74291D104 | 0.629% | $292K | Equity (common) | Corporate | United States | USD |
| 114 | WAVE LIFE SCIENCES LTD WAVE LIFE SCIENCES LTD SHS | SG9999014716 | Not reported | 0.629% | $292K | Equity (common) | Corporate | Singapore | USD |
| 115 | VERA THERAPEUTICS INC VERA THERAPEUTICS INC CL A | US92337R1014 | 92337R101 | 0.628% | $291K | Equity (common) | Corporate | United States | USD |
| 116 | SUMMIT THERAPEUTICS INC SUMMIT THERAPEUTICS INC COM | US86627T1088 | 86627T108 | 0.623% | $289K | Equity (common) | Corporate | United States | USD |
| 117 | TECTONIC THERAPEUTIC INC TECTONIC THERAPEUTIC INC COM | US8789721086 | 878972108 | 0.620% | $288K | Equity (common) | Corporate | United States | USD |
| 118 | IMMATICS NV IMMATICS NV SHS | NL0015285941 | Not reported | 0.619% | $287K | Equity (common) | Corporate | Netherlands | USD |
| 119 | NEWAMSTERDAM PHARMA COMPANY NV NEWAMSTERDAM PHARMA COMPANY NV ORDINARY SHARES | NL00150012L7 | Not reported | 0.612% | $284K | Equity (common) | Corporate | Netherlands | USD |
| 120 | MONTE ROSA THERAPEUTICS INC MONTE ROSA THERAPEUTICS INC COM | US61225M1027 | 61225M102 | 0.607% | $282K | Equity (common) | Corporate | United States | USD |
| 121 | CABALETTA BIO INC CABALETTA BIO INC COM | US12674W1099 | 12674W109 | 0.597% | $277K | Equity (common) | Corporate | United States | USD |
| 122 | INHIBRX BIOSCIENCES INC INHIBRX BIOSCIENCES INC COM | US45720N1037 | 45720N103 | 0.596% | $277K | Equity (common) | Corporate | United States | USD |
| 123 | INTELLIA THERAPEUTICS INC INTELLIA THERAPEUTICS INC COM | US45826J1051 | 45826J105 | 0.591% | $274K | Equity (common) | Corporate | United States | USD |
| 124 | BEAM THERAPEUTICS INC BEAM THERAPEUTICS INC COM | US07373V1052 | 07373V105 | 0.589% | $273K | Equity (common) | Corporate | United States | USD |
| 125 | TANGO THERAPEUTICS INC TANGO THERAPEUTICS INC COM | US87583X1090 | 87583X109 | 0.589% | $273K | Equity (common) | Corporate | United States | USD |
| 126 | CRESCENT BIOPHARMA INC CRESCENT BIOPHARMA INC COM USD0.001 | KYG2545C1042 | Not reported | 0.541% | $251K | Equity (common) | Corporate | Cayman Islands | USD |
| 127 | RELMADA THERAPEUTICS INC RELMADA THERAPEUTICS INC COM | US75955J4022 | 75955J402 | 0.535% | $248K | Equity (common) | Corporate | United States | USD |
| 128 | INVIVYD INC INVIVYD INC COM | US00534A1025 | 00534A102 | 0.465% | $216K | Equity (common) | Corporate | United States | USD |
| 129 | EVOMMUNE INC EVOMMUNE INC COM SHS | US30054Y1073 | 30054Y107 | 0.380% | $176K | Equity (common) | Corporate | United States | USD |
| 130 | BIOAGE LABS INC BIOAGE LABS INC COM | US09077V1008 | 09077V100 | 0.336% | $156K | Equity (common) | Corporate | United States | USD |
| 131 | MAPLIGHT THERAPEUTICS INC MAPLIGHT THERAPEUTICS INC COM | US56565P1030 | 56565P103 | 0.314% | $146K | Equity (common) | Corporate | United States | USD |
| 132 | CAPRICOR THERAPEUTICS INC CAPRICOR THERAPEUTICS INC COM NEW | US14070B3096 | 14070B309 | 0.100% | $46K | Equity (common) | Corporate | United States | USD |